APP-FUBINACA
Chemical compound
From Wikipedia, the free encyclopedia
APP-FUBINACA is an indazole-based synthetic cannabinoid that has been sold online as a designer drug.[1] Pharmacological testing showed APP-FUBINACA to have only moderate affinity for the CB1 receptor, with a Ki of 708 nM, while its EC50 was not tested.[2] It contains a phenylalanine amino acid residue in its structure. [3]
Legal status
- CA: Schedule II
- DE: NpSG (Industrial and scientific use only)
- UK: Class B
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C24H21FN4O2 |
| Molar mass | 416.456 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Legality
Sweden's public health agency suggested to classify APP-FUBINACA as hazardous substance on March 24, 2015.[4]